Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Mitralign Inc. logo — company profile

Mitralign Inc.

Founded 2003 United States Tewksbury, United States 2 employees Series Unknown Total: $174.97M Health Care, Medical Devices

General Information

Company Name Mitralign Inc.
Founded Year 2003
Location United States Tewksbury, United States +1
Employees 2
Industries Health Care, Medical Devices
Funding Stage Series Unknown
Social

Get notified when Mitralign Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Mitralign Inc.

Mitralign, Inc. is a **valve repair company** based near Boston, Massachusetts, USA, founded in **2003**. The company has received a substantial **$9.77M Venture Round investment on February 2, 2018**. Mitralign developed the **Mitralign Percutaneous Annuloplasty System (MPAS)**, a direct transcatheter annuloplasty system designed to address functional tricuspid regurgitation and mitral regurgitation. This innovative therapy targets the reduction of **functional mitral regurgitation (FMR), a life-threatening cardiac condition affecting four million people in the U.S. alone**. Their MPAS is intended for the treatment of symptomatic functional mitral regurgitation (MR ≥ 3+) for annular reduction through tissue plication. Additionally, the company has developed an approach to treating tricuspid valve regurgitation with a delivery system designed for transcatheter tricuspid valve repair. It's essential to note that the **Trialign System is an investigational device** and is limited by Federal (or United States) Law to investigational use only, therefore not available for sale or commercial distribution. The MPAS is also not commercially available in the U.S. **Mitralign** is positioned to provide a **lifeline for millions of patients** who have exhausted other therapeutic options.

Overall, Mitralign offers a promising solution for interventional cardiologists and their patients, addressing a critical unmet need in the treatment of mitral and tricuspid valve regurgitation. With their innovative technology and compelling market potential, the company presents an intriguing opportunity for venture capitalists seeking to invest in the health care industry.

Taxonomy: Medical Innovation, Cardiac Technology, Mitral Valve Repair, Tricuspid Valve Repair, Percutaneous Treatment, Interventional Cardiology, Venture-backed, Catheter-based Technology, Functional Mitral Regurgitation, Transcatheter Annuloplasty, Investigational Device, Top Tier Venture Capitalists, Cardiovascular Device, Startup

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 02 Feb 2018
Series E •••••• - 17 May 2016
Series E •••••• 1
Investor
01 Jan 2015
Venture Round •••••• 1
Investor
20 Jun 2014
Venture Round •••••• 1
Investor
26 Oct 2012

View All 12 Funding Rounds

Mitralign Inc. Alternatives & Competitors

Mitralign Inc. vs
StarTric
StarTric Italy

Transcatether Tricuspid Valve Repair

Seed
2 employees
Manufacturing, Medical Devices
Mitralign Inc. vs
MVRx, Inc.
MVRx, Inc.

Advanced transcatheter therapy for resilient heart health and optimal blood flow

Series Unknown
11-50 employees
Health Care, Health and Wellness
Mitralign Inc. vs
Cardiac Dimensions
Cardiac Dimensions United States

Reshaping the Course of Heart Failure®

Series D
67 employees
Biotechnology, Health Care

FAQ About Mitralign Inc.

Mitralign, Inc. is the valve repair company with the only direct transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. We are a venture-backed, medical innovation company located near Boston, Massachusetts, USA. We’ve developed an inno...
Mitralign Inc. was founded in 2003.
Mitralign Inc. is headquartered in Tewksbury, United States.
Mitralign Inc. operates in the following industries: Health Care, Medical Devices.
Mitralign Inc. has approximately 2 employees.
Mitralign Inc. has completed 12 funding rounds, raising a total of $174.97M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Mitralign Inc. include StarTric, MVRx, Inc., Cardiac Dimensions, HVR Cardio Oy, InnovHeart. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mitralign Inc. and StarTric are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Mitralign Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy